Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Enhancer Hijacking of BCL11B Defines a Subtype of Lineage Ambiguous Acute Leukemia

Blood (2020) 136 (Supplement_2): LBA-3.

https://doi.org/10.1182/blood-2020-143881

Published: 2020

Journal Articles

Mutational Patterns and Correlation to Chip-Related Mutations in Hematological Malignancies - a Study on Mutation Frequencies of 122 Genes in 28 Entities Including 3096 Cases

Anna Stengel, PhD, Constance Baer, PhD, Wencke Walter, PhD, Manja Meggendorfer, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-136288

Published: 2020

Journal Articles

Artificial Intelligence Substantially Supports Chromosome Banding Analysis Maintaining Its Strengths in Hematologic Diagnostics Even in the Era of Newer Technologies

Claudia Haferlach, MD, Siegfried Hänselmann, PhD, Wencke Walter, PhD, Sarah Volkert, Melanie Zenger, Wolfgang Kern, MD, Anna Stengel, PhD, Thomas Lörch, PhD, Torsten Haferlach, MD

Blood (2020) 136 (Supplement 1): 47–48.

https://doi.org/10.1182/blood-2020-137463

Published: 2020

Journal Articles

The Potential of Molecular Genetic Analysis for Diagnostic and Prognostic Decision Making in Clonal Cytopenia of Undetermined Significance (CCUS) and MDS - a Study on 576 Patients

Constance Baer, PhD, Anna Stengel, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2020) 136 (Supplement 1): 30–31.

https://doi.org/10.1182/blood-2020-136557

Published: 2020

Journal Articles

T-Cell Acute Lymphoblastic Leukemia Can be Subdivided into Six Genetically Distinct Subtypes with Prognostic Impact By Combination of Whole Genome and Whole Transcriptome Data

Janine Müller, PhD, Claudia Haferlach, MD, Henning Ruge, PhD, Heiko Müller, PhD, Irene Fuhrmann, Manja Meggendorfer, PhD, Martha-Lena Müller, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Anna Stengel, PhD

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-136554

Published: 2020

Journal Articles

Correlation of Mutation Patterns with Patient Age in 2656 Cases with 11 Different Hematological Malignancies

Anna Stengel, PhD, Manja Meggendorfer, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2020) 136 (Supplement 1): 16–17.

https://doi.org/10.1182/blood-2020-136545

Published: 2020

Journal Articles

The Diverse Landscape of Fusion Transcripts in 25 Different Hematological Entities

Claudia Haferlach, MD, Wencke Walter, PhD, Manja Meggendorfer, PhD, Constance Baer, PhD, Anna Stengel, PhD, Stephan Hutter, PhD, Niroshan Nadarajah, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2020) 136 (Supplement 1): 16–17.

https://doi.org/10.1182/blood-2020-137518

Published: 2020

Journal Articles

Comprehensive Analysis of 22 Cases with Blastic Plasmacytoid Dendritic Cell Neoplasm Reveals Mutations in DNA Repair Genes and Two Distinct Subgroups Defined By Differential Gene Expression with Prognostic Impact

Anna Stengel, PhD, Wencke Walter, PhD, Constance Baer, PhD, Manja Meggendorfer, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2019) 134 (Supplement_1): 1234.

https://doi.org/10.1182/blood-2019-125645

Published: 2019

Journal Articles

Molecular Classification of AML-MRC Reveals a Distinct Profile and Identifies MRC-like Patients with Poor Overall Survival

Constance Baer, PhD, Wencke Walter, PhD, Anna Stengel, PhD, Stephan Hutter, PhD, Manja Meggendorfer, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2019) 134 (Supplement_1): 2735.

https://doi.org/10.1182/blood-2019-128234

Published: 2019

Journal Articles

Comprehensive Analysis of MYC Translocations in Multiple Myeloma By Whole Genome Sequencing and Whole Transcriptome Sequencing

Sonja Seliger, Verena Geirhos, Torsten Haferlach, MD, Wolfgang Kern, MD, Wencke Walter, PhD, Manja Meggendorfer, PhD, Constance Baer, PhD, Anna Stengel, PhD, Claudia Haferlach, MD

Blood (2019) 134 (Supplement_1): 1774.

https://doi.org/10.1182/blood-2019-124704

Published: 2019

Journal Articles

Primary and Secondary Hematological Neoplasms - Are They Related?

Claudia Haferlach, MD, Constance Baer, PhD, Stephan Hutter, PhD, Anna Stengel, PhD, Niroshan Nadarajah, Wencke Walter, PhD, Manja Meggendorfer, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2019) 134 (Supplement_1): 1702.

https://doi.org/10.1182/blood-2019-126585

Published: 2019

Journal Articles

Application of RNA Sequencing Detects a Large Number of Novel Fusion Transcripts in Patients with AML and MDS

Anna Stengel, PhD, Rabia Shahswar, MD, Wencke Walter, PhD, Manja Meggendorfer, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2019) 134 (Supplement_1): 887.

https://doi.org/10.1182/blood-2019-124310

Published: 2019

Journal Articles

Therapy-Related Myeloid Neoplasms (tMN) Following Treatment of Acute Myeloid Leukemia (AML): Exome Sequencing Reveals the Presence of an Ancestral Clone Refractory to Chemotherapy

Luise Hartmann, PhD, Niroshan Nadarajah, Manja Meggendorfer, PhD, Alexander Höllein, MD, Calogero Vetro, MD, Anna Stengel, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2018) 132 (Supplement 1): 1462.

https://doi.org/10.1182/blood-2018-99-112924

Published: 2018

Journal Articles

Molecular Characterization of Acute Myeloid Leukemia (AML) Patients Who Relapse More Than 3 Years after Diagnosis: An Exome Sequencing Study of 31 Patients

Luise Hartmann, PhD, Niroshan Nadarajah, Manja Meggendorfer, PhD, Anna Stengel, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2018) 132 (Supplement 1): 1463.

https://doi.org/10.1182/blood-2018-99-112940

Published: 2018

Journal Articles

Whole Genome Sequencing and RNA Sequencing of 27 Patients with Persistent Polyclonal B-Cell Lymphocytosis Reveals a High Mutation Frequency/Overexpression of Lymphoma Associated Genes: Really a Benign Disorder?

Anna Stengel, PhD, Alexander Höllein, MD, Wolfgang Kern, MD, Manja Meggendorfer, PhD, Claudia Haferlach, MD, Wencke Walter, PhD, Stephan Hutter, PhD, Torsten Haferlach, MD

Blood (2018) 132 (Supplement 1): 924.

https://doi.org/10.1182/blood-2018-99-111480

Published: 2018

Journal Articles

Analysis of BRCA1 and BRCA2 Mutations and Gene Expression in Hematological Malignancies - Implications for Differential Involvement in Pathogenesis of Lymphoid Neoplasms

Anna Stengel, PhD, Wencke Walter, PhD, Stephan Hutter, PhD, Wolfgang Kern, MD, Manja Meggendorfer, PhD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2018) 132 (Supplement 1): 1348.

https://doi.org/10.1182/blood-2018-99-111826

Published: 2018

Journal Articles

Mutational Landscape of the Transcriptome Offers a Rich Neoantigen Resource for Immunotherapy of Myeloproliferative Neoplasms

Blood (2018) 132 (Supplement 1): 3058.

https://doi.org/10.1182/blood-2018-99-118049

Published: 2018

Journal Articles

Impact of 9q Deletions on the Classification in AML

Bettina Balk, Anna Stengel, PhD, Manja Meggendorfer, PhD, Annette Fasan, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2017) 130 (Supplement 1): 3925.

https://doi.org/10.1182/blood.V130.Suppl_1.3925.3925

Published: 2017

Journal Articles

High Grade B Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements Depict a High Complexity on the Cytogenetic, but Not on the Molecular Genetic Level and Show MYC Mutations As Prognostic Marker

Anna Stengel, PhD, Wolfgang Kern, MD, Manja Meggendorfer, PhD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2017) 130 (Supplement 1): 4001.

https://doi.org/10.1182/blood.V130.Suppl_1.4001.4001

Published: 2017

Journal Articles

Comprehensive Molecular Characterization of Myeloid Malignancies with 9q Deletion

Luise Hartmann, PhD, Torsten Haferlach, MD, Manja Meggendorfer, PhD, Annette Fasan, PhD, Anna Stengel, PhD, Melanie Zenger, Kathleen Zieschang, Wolfgang Kern, MD, Claudia Haferlach, MD

Blood (2017) 130 (Supplement 1): 2953.

https://doi.org/10.1182/blood.V130.Suppl_1.2953.2953

Published: 2017

NARROW

Enhancer Hijacking of BCL11B Defines a Subtype of Lineage Ambiguous Acute Leukemia

Mutational Patterns and Correlation to Chip-Related Mutations in Hematological Malignancies - a Study on Mutation Frequencies of 122 Genes in 28 Entities Including 3096 Cases

Artificial Intelligence Substantially Supports Chromosome Banding Analysis Maintaining Its Strengths in Hematologic Diagnostics Even in the Era of Newer Technologies

The Potential of Molecular Genetic Analysis for Diagnostic and Prognostic Decision Making in Clonal Cytopenia of Undetermined Significance (CCUS) and MDS - a Study on 576 Patients

T-Cell Acute Lymphoblastic Leukemia Can be Subdivided into Six Genetically Distinct Subtypes with Prognostic Impact By Combination of Whole Genome and Whole Transcriptome Data

Correlation of Mutation Patterns with Patient Age in 2656 Cases with 11 Different Hematological Malignancies

The Diverse Landscape of Fusion Transcripts in 25 Different Hematological Entities

Comprehensive Analysis of 22 Cases with Blastic Plasmacytoid Dendritic Cell Neoplasm Reveals Mutations in DNA Repair Genes and Two Distinct Subgroups Defined By Differential Gene Expression with Prognostic Impact

Molecular Classification of AML-MRC Reveals a Distinct Profile and Identifies MRC-like Patients with Poor Overall Survival

Comprehensive Analysis of MYC Translocations in Multiple Myeloma By Whole Genome Sequencing and Whole Transcriptome Sequencing

Primary and Secondary Hematological Neoplasms - Are They Related?

Application of RNA Sequencing Detects a Large Number of Novel Fusion Transcripts in Patients with AML and MDS

Therapy-Related Myeloid Neoplasms (tMN) Following Treatment of Acute Myeloid Leukemia (AML): Exome Sequencing Reveals the Presence of an Ancestral Clone Refractory to Chemotherapy

Molecular Characterization of Acute Myeloid Leukemia (AML) Patients Who Relapse More Than 3 Years after Diagnosis: An Exome Sequencing Study of 31 Patients

Whole Genome Sequencing and RNA Sequencing of 27 Patients with Persistent Polyclonal B-Cell Lymphocytosis Reveals a High Mutation Frequency/Overexpression of Lymphoma Associated Genes: Really a Benign Disorder?

Analysis of BRCA1 and BRCA2 Mutations and Gene Expression in Hematological Malignancies - Implications for Differential Involvement in Pathogenesis of Lymphoid Neoplasms

Mutational Landscape of the Transcriptome Offers a Rich Neoantigen Resource for Immunotherapy of Myeloproliferative Neoplasms

Impact of 9q Deletions on the Classification in AML

High Grade B Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements Depict a High Complexity on the Cytogenetic, but Not on the Molecular Genetic Level and Show MYC Mutations As Prognostic Marker

Comprehensive Molecular Characterization of Myeloid Malignancies with 9q Deletion

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only